Method of controlling the release of an active ingredient from a dosage form

Patent metadata

Field	Value
Publication number	US-9693959-B2
Application number	US-201113156889-A
Country	US
Kind code	B2
Filing date	Jun 9, 2011
Priority date	Jul 28, 2010
Publication date	Jul 4, 2017
Grant date	Jul 4, 2017

Abstract

A method of controlling or adjusting release of an active ingredient from a dosage form comprising the active ingredient and a polysaccharide derivative has been found. The method comprises the steps of
a) providing a composition comprising a polysaccharide derivative and a controlled amount of a liquid diluent, based on the dry weight of the polysaccharide derivative, b) subjecting the composition to a dry-grinding operation to provide a dry-ground polysaccharide derivative, and c) incorporating the dry-ground polysaccharide derivative and an active ingredient into a dosage form.

First claim

What is claimed is:

1. A method of controlling or adjusting release of an active ingredient from a dosage form comprising the active ingredient and a polysaccharide derivative, which method comprises the steps of
a) providing a composition comprising a polysaccharide derivative and a controlled amount of a liquid diluent, based on the dry weight of the polysaccharide derivative,
b) subjecting the composition to a dry-grinding operation to provide a dry-ground polysaccharide derivative, and
c) then combining the dry-ground polysaccharide derivative and an active ingredient, and incorporating them into a dosage form,
wherein the release of the active ingredient from the dosage form is controlled and adjusted by controlling and adjusting the amount of the liquid diluent, based on the dry weight of the polysaccharide derivative in step a), and wherein the polysaccharide derivative is selected from the group consisting of methyl cellulose, methyl hydroxyethyl cellulose, methyl hydroxypropyl cellulose and hydroxypropyl cellulose, and
wherein the release of the active ingredient from the dosage form at a given time is adjusted to a first value by a first amount of the liquid diluent, based on the dry weight of the polysaccharide derivative in step a), and the release of the active ingredient from the dosage form at the given time is adjusted to a second value by a second amount of the liquid diluent, based on the dry weight of the polysaccharide derivative in step a).

2. A method of controlling or adjusting release of an active ingredient from a dosage form comprising the active ingredient and a polysaccharide derivative, which method comprises the steps of
a) providing a composition comprising a polysaccharide derivative and a controlled amount of a liquid diluent, based on the dry weight of the polysaccharide derivative,
b) subjecting the composition to a dry-grinding operation to provide a dry-ground polysaccharide derivative, and
c) then combining the dry-ground polysaccharide derivative and an active ingredient, and incorporating them into a dosage form,
wherein the release of the active ingredient from the dosage form is controlled and adjusted by controlling and adjusting the amount of the liquid diluent, based on the dry weight of the polysaccharide derivative in step a), and wherein the polysaccharide derivative is selected from the group consisting of methyl cellulose, methyl hydroxyethyl cellulose, methyl hydroxypropyl cellulose and hydroxypropyl cellulose, and
wherein the amount of the liquid diluent is controlled in such an amount that the composition in step a) comprises from 0.4 to 50 weight parts of the liquid diluent per weight part of dry polysaccharide derivative, and the composition is subjected in step b) to a dry-grinding operation to provide a dry-ground polysaccharide derivative comprising from 0.01 to 0.25 weight parts of liquid diluent per weight part of dry polysaccharide derivative.

Assignees

• Goerlach-Doht Yvonne M
• Hermanns Juergen
• Grasman Nicholas S
• Dow Global Technologies Llc

Inventors

• Goerlach-Doht Yvonne M
• Hermanns Juergen
• Grasman Nicholas S

Classifications

• A61P9/12

  Antihypertensives · CPC title

• A61P9/04

  Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure · CPC title

• A61P3/06

  Antihyperlipidemics · CPC title

• A61P31/10

  Antimycotics · CPC title

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title